GLICLAZIDE (UK) is a sulfonylurea oral hypoglycemic agent used to manage type 2 diabetes mellitus. It works by stimulating insulin secretion from pancreatic beta cells, thereby lowering blood glucose levels. This medication is particularly effective for patients who require additional glycemic control beyond lifestyle modifications. GLICLAZIDE is known for its sustained-release formulation, which provides consistent blood sugar management throughout the day. It is suitable for adults with type 2 diabetes and is often prescribed when diet and exercise alone are insufficient.